For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Bristol-myers Squibb

USPTO Granted Patents = 39

EPO Patents = 1

Forward Citations = 1,602

Loading Chart...

Loading Chart...

111 inventors (with patents filed for the assignee):

Chandra S Ramanathan (4 out of 33 patents)

William R Ewing (3 out of 85 patents)

Jeffrey A Robl (3 out of 81 patents)

4. John N Feder (3 out of 67 patents)

5. Paolo Lombardi (3 out of 31 patents)

6. Fabio Animati (3 out of 7 patents)

7. Andrew K Dilger (2 out of 17 patents)

8. Kumar Balashanmuga Pabbisetty (2 out of 13 patents)

9. Yeheng Zhu (2 out of 19 patents)

10. Stephen H Hoag (2 out of 22 patents)

11. James R Corte (2 out of 65 patents)

12. Kwan-Ho Chan (2 out of 36 patents)

13. Hajime Kamachi (2 out of 29 patents)

14. Clair L Strohl (2 out of 6 patents)

15. Jeffrey B Boggs (2 out of 3 patents)

39 patents: Sort by Forward Citations

1. 10287288 - Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties (2019-05-14),

2. 10273236 - Macrocyclic factor XIa inhibitors bearing heterocyclic groups (2019-04-30),

3. 9273111 - Therapeutic TREM-1 peptides (2016-03-01),

4. 7153678 - Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof (2006-12-26),

5. 7115375 - Methods of diagnosing renal tumors by determining the expression level of RNA encoding the HGPRBMY18 polypeptide (2006-10-03),

6. 7094572 - Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 (2006-08-22),

7. 7041496 - DNA encoding rodent KCNQ2 potassium channel (2006-05-09),

8. 7037910 - Azabicyclic heterocycles as cannabinoid receptor modulators (2006-05-02),

9. 7037906 - Methods for modulating tumor growth and metastasis (2006-05-02),

10. 7037676 - Drosophila tumor necrosis factor class molecule polynucleotides and variants thereof (2006-05-02),

11. 6330845 - Wrench for an implant (2001-12-18),

12. 6214869 - Heterocyclic cis cyclopropane derivatives as melatonergic agents (2001-04-10),

13. 6187008 - Device for temporarily fixing bones (2001-02-13),

14. 6184231 - 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators (2001-02-06),

15. 6180651 - Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics (2001-01-30),

Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines for patients with serious diseases. With a focus on cancer, cardiovascular, immunoscience and fibrosis, the company's mission is to help patients prevail over serious diseases. Bristol-Myers Squibb is dedicated to advancing scientific knowledge and furthering medical research to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

39 Patents

#29 in Princeton, NJ

#354 in New Jersey

#8,539 in US

#16,944 in the World

Princeton, NJ, United States of America

Bristol-myers Squibb

Forward Citations = 1,602

111 inventors:

Chandra S Ramanathan (4 out of 33 patents)

William R Ewing (3 out of 85 patents)

Jeffrey A Robl (3 out of 81 patents)

4. John N Feder (3 out of 67 patents)

5. Paolo Lombardi (3 out of 31 patents)

Please report any incorrect information to support@idiyas.com

Loading…